Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03842293 · ClinicalTrials.gov registry record
Clinical Evaluation of PROMIS in CKD
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 213
- Enrollment target
NCT03842293: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT03842293 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 213 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03842293 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 213 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the clinical validity of a set of PROMIS pediatric person-reported outcome measures in patients with chronic kidney disease. The evaluation includes longitudinal assessments of how measures change in association with clinical changes.
Primary Outcome
Child self-report of 8 items from PROMIS sleep-related disturbance domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2017-06-22 |
| Est. Completion | 2020-08-30 |
What the finished NCT03842293 record still lists
NCT03842293 is an observational study that tracks outcomes without assigning an intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03842293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03842293 about?
NCT03842293 is a clinical study titled "Clinical Evaluation of PROMIS in CKD". The purpose of this study is to evaluate the clinical validity of a set of PROMIS pediatric person-reported outcome measures in patients with chronic kidney disease. The evaluation includes longitudinal assessments of how measures change in association with clinical changes.
What is the current status of trial NCT03842293?
This trial is currently completed. The enrollment target is 213 participants. The study started on 2017-06-22. Estimated completion is 2020-08-30.
Who is sponsoring clinical trial NCT03842293?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI